Category: Series
-
![This week in crypto: slouching towards a cautiously optimistic future edition]()
This week in crypto: slouching towards a cautiously optimistic future edition
It’s difficult to pinpoint exactly why confidence in Bitcoin’s future has jumped, but the likely culprit is that the Chinese bitcoin miners recently exiled from their ancestral homelands have made their way to to North America (and Russia and Kazakhstan) and set up shop. The hashrate and mining difficulty both enjoyed a bump, and now…
-
![To Invest or Not: Diagnos (ADK.V)]()
To Invest or Not: Diagnos (ADK.V)
In this episode, we talk about DIAGNOS (ADK.V), a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging, and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment. We discuss what they do,…
-
![Chris’ Corner: Diagnos Inc (ADK.V)]()
Chris’ Corner: Diagnos Inc (ADK.V)
Chris Parry speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an in-depth look at how their diabetic retinopathy screening services work and what it means for optometrists and patients. Tune in!
-
![Diagnos (ADK.V) Renews Contract with Optina Diagnostics]()
Diagnos (ADK.V) Renews Contract with Optina Diagnostics
Diagnos (ADK.V) today announced a contract renewal to provide its telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics for an additional three-year period. “This contract renewal is a testimony of the high quality of our telemedicine platform and the agility of DIAGNOS people to adapt its platform to enable the rich…
-
![Altan Rio Minerals (AMO.V) poised to unlock gold-rich potential at its Southern Cross Project in Western Australia]()
Altan Rio Minerals (AMO.V) poised to unlock gold-rich potential at its Southern Cross Project in Western Australia
In light of recent trading action—an early August flash crash followed by a nice stair-stepping sequence higher—we may have printed a bottom in the precious metal arena, and a new bull run may be on the horizon. For those looking for exposure to precious metals—for those conducting due diligence in this wild west of an…
-
![To Invest or Not: Kwesst Micro Systems (KWE.V)]()
To Invest or Not: Kwesst Micro Systems (KWE.V)
In this episode, we take a look at Kwesst Micro Systems (KWE.V). A tech company that develops and commercializes ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defense and security community. Tune in!
-
![Today’s Idea: Kwesst Micro Systems (KWE.V) isn’t guided by the beauty of their weapons]()
Today’s Idea: Kwesst Micro Systems (KWE.V) isn’t guided by the beauty of their weapons
I knew I wouldn’t remember the name, make and model of the rifle in three months time, but I’ll never forget the way it rested, the butt snug and comfortable in my shoulder, like we were made for each other. We were somewhere south of Mission B.C.—having traded in our Honda Civic for our friend…
-
![Today’s Idea: Kwesst Micro Systems (KWE.V) isn’t guided by the beauty of their weapons]()
Today’s Idea: Kwesst Micro Systems (KWE.V) isn’t guided by the beauty of their weapons
I knew I wouldn’t remember the name, make and model of the rifle in three months time, but I’ll never forget the way it rested, the butt snug and comfortable in my shoulder, like we were made for each other. We were somewhere south of Mission B.C.—having traded in our Honda Civic for our friend…
-
![First Glance with Jody Vance – Medexus Pharma (MDP.T)]()
First Glance with Jody Vance – Medexus Pharma (MDP.T)
Vancouver’s own Jody Vance speaks with Ken d’Entremont, Medexus Pharmaceuticals (MDP.V) CEO and director, to find out more about the company’s mandate of bringing established drugs approved in other countries to patients in Canada. Listen in! <div algn=”center:><iframe width=”803″ height=”452″ src=”https://www.youtube.com/embed/r4MwrGgePDo” title=”YouTube video player” frameborder=”0″ allow=”accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture” allowfullscreen></iframe></div>
-
![Today’s Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the North American Pharmaceuticals Ladder]()
Today’s Idea: Medexus Pharmaceuticals (MDP.T) Continues to Climb the North American Pharmaceuticals Ladder
Cancer is a bitch. Even if you haven’t had to battle against cancer yourself, you likely know someone who has. Unfortunately for me, that person was my mom; however, before this turns into a sob story let me assure you that my mom is alive and well after kicking cancer’s ass. My mom was diagnosed…
